229 related articles for article (PubMed ID: 26634569)
1. Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.
Christidis N; Omrani S; Fredriksson L; Gjelset M; Louca S; Hedenberg-Magnusson B; Ernberg M
J Headache Pain; 2015; 16():104. PubMed ID: 26634569
[TBL] [Abstract][Full Text] [Related]
2. Changes of hypertonic saline-induced masseter muscle pain characteristics, by an infusion of the serotonin receptor type 3 antagonist granisetron.
Christidis N; Ioannidou K; Milosevic M; Segerdahl M; Ernberg M
J Pain; 2008 Oct; 9(10):892-901. PubMed ID: 18585094
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular injection of granisetron into the masseter muscle increases the pressure pain threshold in healthy participants and patients with localized myalgia.
Christidis N; Nilsson A; Kopp S; Ernberg M
Clin J Pain; 2007; 23(6):467-72. PubMed ID: 17575485
[TBL] [Abstract][Full Text] [Related]
4. Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders.
Voog O; Alstergren P; Leibur E; Kallikorm R; Kopp S
Life Sci; 2000 Dec; 68(5):591-602. PubMed ID: 11197756
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
Ernberg M; Hedenberg-Magnusson B; List T; Svensson P
Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731
[TBL] [Abstract][Full Text] [Related]
6. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia.
Ernberg M; Lundeberg T; Kopp S
Pain; 2003 Feb; 101(3):275-282. PubMed ID: 12583870
[TBL] [Abstract][Full Text] [Related]
7. Influence of intramuscular granisetron on experimentally induced muscle pain by acidic saline.
Louca S; Ernberg M; Christidis N
J Oral Rehabil; 2013 Jun; 40(6):403-12. PubMed ID: 23520976
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle.
Ernberg M; Lundeberg T; Kopp S
Pain; 2000 Feb; 84(2-3):339-46. PubMed ID: 10666539
[TBL] [Abstract][Full Text] [Related]
9. Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.
Nitecka-Buchta A; Walczynska-Dragon K; Batko-Kapustecka J; Wieckiewicz M
Pain Res Manag; 2018; 2018():8261090. PubMed ID: 29973970
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine Injection in the Intramuscular Innervation Zone Can Effectively Treat Chronic Neck Pain Caused by MTrPs in the Trapezius Muscle.
Xie P; Qin B; Yang F; Yu T; Yu J; Wang J; Zheng H
Pain Physician; 2015; 18(5):E815-26. PubMed ID: 26431135
[TBL] [Abstract][Full Text] [Related]
12. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis.
Voog U; Alstergren P; Leibur E; Kallikorm R; Kopp S
Mediators Inflamm; 2004 Dec; 13(5-6):373-6. PubMed ID: 15770056
[TBL] [Abstract][Full Text] [Related]
13. Granisetron vs. lidocaine injection to trigger points in the management of myofascial pain syndrome: a double-blind randomized clinical trial.
Rezasoltani Z; Ehyaie H; Mofrad RK; Vashaei F; Mohtasham R; Najafi S
Scand J Pain; 2021 Oct; 21(4):707-715. PubMed ID: 33691056
[TBL] [Abstract][Full Text] [Related]
14. The effect on mechanical pain threshold over human muscles by oral administration of granisetron and diclofenac-sodium.
Christidis N; Kopp S; Ernberg M
Pain; 2005 Feb; 113(3):265-270. PubMed ID: 15661432
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
16. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
17. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
Guarda-Nardini L; Stecco A; Stecco C; Masiero S; Manfredini D
Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
19. Effect of adding cervical facet joint injections in a multimodal treatment program for long-standing cervical myofascial pain syndrome with referral pain patterns of cervical facet joint syndrome.
Park SC; Kim KH
J Anesth; 2012 Oct; 26(5):738-45. PubMed ID: 22648287
[TBL] [Abstract][Full Text] [Related]
20. Iliocostalis Thoracis-Lumborum Myofascial Pain: Reviewing a Subgroup of a Prospective, Randomized, Blinded Trial. A Challenging Diagnosis with Clinical Implications.
Roldan CJ; Huh BK
Pain Physician; 2016 Jul; 19(6):363-72. PubMed ID: 27454266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
